Treatments Archives - Neurology Advisor

Child sitting backwards on a couch, autism

Intranasal Oxytocin Therapy Shows No Benefit for Children With ASD

October 19, 2021

For children with ASD, the administration of intranasal oxytocin therapy during a 24-week period does not significantly improve the score for a measure of social interaction.

Anesthesiologist inject medical solution to spinal

General Neurology

Cerebrospinal Fluid Diffusion of Bictegravir/Emtricitabine/Tenofovir in HIV-Related Central Nervous System Impairment

By

Sweta Gupta

October 15, 2021

Researchers sought to determine the effects and cerebrospinal fluid concentrations of treatment with bictegravir, emtricitabine, and tenofovir in patients with HIV-related central nervous system impairment.

Currently, there are no pharmacological treatments that prevent SUDEP, and the only drugs associated with reduced SUDEP risk are antiepileptic agents.2 Therefore, patients should be counseled on the importance of complying with their antiseizure medications to reduce their risk of SUDEP. Because increased levels of various regulatory hormones and neurotransmitters following seizure activity have been associated with SUDEP, drugs that modify serotonin, adenosine, and other neurotransmitters might eventually be shown to prevent SUDEP, but research is ongoing.2

Epilepsy

Use of Enzyme-Inducing Antiseizure Meds May Increase Long-Term CVD Risk

October 15, 2021

There appears to be a dose-dependent risk for incident cardiovascular disease associated with enzyme-inducing antiseizure medications.

Migraine and Headache

Qulipta Approved for Preventive Treatment of Episodic Migraine

By

Brian Park, PharmD

October 8, 2021

Results from ADVANCE showed statistically significantly greater decreases in mean monthly migraine days with atogepant compared with placebo.

Multiple Sclerosis

The Effect of MS Treatments on SARS-CoV-2 Vaccines and the Humoral Response

By

Amit Akirov, MD

October 6, 2021

Researchers determined the impact of other disease-modifying treatments in multiple sclerosis and the effect of delaying anti-CD20 infusion on the humoral response to COVID-19 vaccines.

Alzheimer's Disease and Dementia

Levetiracetam Well Tolerated for Alzheimer Disease

October 1, 2021

For patients with Alzheimer disease (AD), levetiracetam is well tolerated and improves performance on certain cognitive tasks among those with epileptiform activity.

General Medicine

DEA Warns of Fentanyl in Counterfeit Opioid Pills

October 4, 2021

People buying pills that look like prescription opioid painkillers or stimulants who are not buying them from a licensed pharmacy may be buying a lethal drug.

Neurobehavioral Disorders

Relapse Risk Increased With Antidepressant Therapy Discontinuation

October 1, 2021

For patients with depression who feel well enough to discontinue antidepressant therapy, the risk for relapse is increased for those who discontinue their medication.